Fundraising Fox

Equilibre Biopharmaceuticals

New York, US · Founded 2020 · Delaware corporation · 1 known investors

eqneuro.com ↗
Biotech

Founders & leadership

SG
Steven GordonExecutive Officer
SW
Sam WaksalExecutive Officer
FM
Francois MaisonrougeDirector
JM
Joel MarcusDirector
DF
David FriedmanDirector

Investors · 1

Third Point VenturesMenlo Park

Reported raises · per SEC filings

Form D private placements
▶$6MraisedDec 2022 · 13 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Philip A. BarachExecutive Officer, Director
  • Christopher ThornExecutive Officer
  • Christina RamirezDirector
  • Peter M. SimonDirector
  • David FriedmanDirector
  • Steven N. GordonExecutive Officer, Director
  • Francois MaisonrougeDirector
Offering amount
$6M
Amount sold
$6M
First sale
Nov 2022
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15.9MraisedJan 2022 · 14 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter SimonDirector
  • David FriedmanDirector
  • Francois MaisonrougeDirector
  • Philip BarachDirector
  • Steven GordonExecutive Officer, Director
  • Samuel WaksalExecutive Officer, Director
  • Joel MarcusDirector
Offering amount
$25M
Amount sold
$15.9M
First sale
Jan 2022
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$25.8MraisedNov 2020 · 14 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven GordonExecutive Officer
  • Sam WaksalExecutive Officer
  • Francois MaisonrougeDirector
  • Joel MarcusDirector
  • David FriedmanDirector
Offering amount
$35.8M
Amount sold
$25.8M
First sale
Nov 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.